A reassessment of 8-anilino-1-naphthalene sulphonic acid as a thyroxine binding inhibitor in the radioimmunoassay of thyroxine.
The effectiveness of 8-anilino-1-naphthalene sulphonic acid (ANS) in the radioimmunoassay (RIA) of thyroxine (T4) as an inhibitor of the binding of T4 to serum T4-binding proteins is assessed. The optimum ANS concentration is dependent upon the antiserum and the method used for separating free and bound T4. If T4 binding to serum proteins is not completely inhibited, resin separation methods may yield low values, while polyethylene glycol and double-antibody methods may produce high values for T4 concentration. Even with optimum ANS concentration gross errors in measurement of T4 may occur in patients with high thyroxine-binding globulin (TBG) concentrations.
D000817:Anilino Naphthalenesulfonates / Q000494:pharmacology*; D003276:Contraceptives, Oral; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood; D011247:Pregnancy; D011863:Radioimmunoassay / Q000379:methods; D013974:Thyroxine / Q000097:blood*; D013975:Thyroxine-Binding Proteins / Q000037:antagonists & inhibitors / Q000097:blood*
D000817:Anilino Naphthalenesulfonates; D003276:Contraceptives, Oral; D013975:Thyroxine-Binding Proteins; D013974:Thyroxine